M.F. Bromelain By Thorne Research Overview & Drug Interactions
Check For Interactions With M.F. Bromelain
Supplement: M.F. Bromelain by Thorne Research
M.F. Bromelain Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Bromelain
Bromelain is a group of proteolytic enzymes derived from pineapples. It has been traditionally used for its anti-inflammatory and protein-digesting properties. Some research suggests it may have potential benefits for conditions such as allergic rhinitis, burns, cancer, diabetic foot ulcers, and postoperative pain, among others. However, the evidence for its effectiveness in these areas is lacking, and more research is needed. It is important to note that bromelain should not be confused with other protein-digesting enzymes. Pregnant and lactating individuals should avoid using bromelain due to insufficient information about its safety in these populations.
See More Information Regarding Bromelain| Ingredient Group | Bromelain |
|---|---|
| Category | enzyme |
- Pineapple
Drugs that interact with M.F. Bromelain by Thorne Research
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
2 Capsule(s)
|
| Maximum serving Sizes: |
2 Capsule(s)
|
| Servings per container | 30 |
| UPC/BARCODE | 693749006428 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Bromelain |
1 Gram(s)
|
Bromelain |
--
|
| Other Ingredients: |
Hypromellose (derived from Cellulose) Capsule
Forms
Leucine
Silicon Dioxide
|
|---|
Label Statments:
| FDA Disclaimer Statement |
- This statement has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
- These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
|
|---|---|
| FDA Statement of Identity |
- Dietary Supplement
|
| General |
- SF103 CTNSF103B02
|
| Suggested/Recommended/Usage/Directions |
- Suggested Use: Take 2 capsules one to three times daily or as recommended by your health-care practitioner.
- M.F. Bromelain
To help decrease swelling after injury
1 capsule with breakfast
1 capsule with dinner
Note: The suggested use above is specific for aiding in the healing process, and is not necessarily the same suggested use on individual bottles.
|
| Precautions |
- Tamper Evident: Use only if bottle is sealed.
- If pregnant, consult your health-care practitioner before using this product.
|
| Storage |
- Store tightly sealed in a cool, dry place.
|
| General Statements |
- This product is not diluted with lactose.
- SB315
- Safe, effective nutritional formulas to support your healing process after injury, trauma, or surgery
|
| Brand IP Statement(s) |
- M.F. Bromelain
(1 bottle of 60 capsules)
|
Brand Information
See all products by this brand
| Manufactured by: | |
|---|---|
| Name | Thorne Research, Inc. |
| Street Address | P.O. Box 25 |
| City | Dover |
| State | Idaho |
| Country | USA |
| ZipCode | 83825 |
| Phone Number | 1-800-228-1966 |
| Web Address | www.thorne.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.